TA
CME icon

Townsend & Associates’s CME Group CME Stock Holding History

Townsend & Associates’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.2M Buy
65,960
+1,827
+3% +$505K 1.38% 31
2026
Q1 		$18.3M Buy
64,133
+1,319
+2% +$392K 1.58% 23
2025
Q4 		$17.1M Buy
62,814
+1,010
+2% +$274K 1.53% 26
2025
Q3 		$16.6M Buy
61,804
+1,822
+3% +$496K 1.57% 24
2025
Q2 		$16.8M Sell
59,982
-11,046
-16% -$3M 1.66% 21
2025
Q1 		$18.5M Sell
71,028
-6,129
-8% -$1.51M 1.93% 16
2024
Q4 		$17.9M Buy
77,157
+1,571
+2% +$361K 1.84% 23
2024
Q3 		$17.2M Buy
75,586
+2,465
+3% +$510K 1.76% 23
2024
Q2 		$14.7M Buy
73,121
+1,813
+3% +$375K 1.63% 28
2024
Q1 		$15.5M Buy
71,308
+1,360
+2% +$286K 1.8% 23
2023
Q4 		$14.3M Buy
69,948
+27,041
+63% +$5.77M 1.79% 19
2023
Q3 		$8.97M Buy
42,907
+12,489
+41% +$2.48M 1.89% 16
2023
Q2 		$5.82M Buy
30,418
+9,201
+43% +$1.7M 1.5% 21
2023
Q1 		$3.94M Buy
21,217
+14,540
+218% +$2.63M 1.58% 21
2022
Q4 		$1.24M Buy
+6,677
New +$1.16M 0.61% 56

Other funds holding CME

PAM
PineStone Asset Management Montreal, Quebec, Canada $16.2B AUM 25.74% 1-Year Est. Return
SP
Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
GAM
Guinness Asset Management London, United Kingdom $5.91B AUM 21.44% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
SLAM
Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
JSSH
J. Safra Sarasin Holding $6.97B AUM 32.91% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return

Townsend & Associates's CME Position: Q2 2026 in Review

Townsend & Associates increased its CME Group (CME) stake by 2.8% in Q2 2026, buying an estimated $505K and bringing the position to 65,960 shares worth $16.2M. The position accounts for 1.38% of the portfolio, ranked #31.

Townsend & Associates first reported a position in CME in Q4 2022 and has held it in 15 quarters since. The position peaked at $18.5M in Q1 2025. 670 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Townsend & Associates held 65,960 shares of CME Group worth $16.2M as of Q2 2026.
  • Townsend & Associates bought 1,827 CME Group shares in Q2 2026, an estimated $505K.
  • CME Group made up 1.38% of Townsend & Associates's portfolio in Q2 2026, its #31 holding.
  • Townsend & Associates first reported a position in CME Group in Q4 2022 and has held it in 15 quarters since.
  • Townsend & Associates's CME Group position peaked at $18.5M in Q1 2025.
  • 670 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Townsend & Associates's 13F filing for Q2 2026, filed 22 Jul 2026.